Archive for January, 2008



FDA Grants Priority Review For Velcade(R) (bortezomib) for Injection In Patients with Newly Diagnosed Multiple Myeloma

Thursday, January 31st, 2008

Millennium Pharmaceuticals, Inc. ( NASDAQ:MLNM ) today announced the U.S. Food and Drug Administration (FDA) granted priority review for VELCADE in patients with newly diagnosed multiple myeloma (MM).(original article)

Review Compares Latest Birth Control Options

Thursday, January 31st, 2008

With many women still searching for the perfect birth control method, a systematic review analyzes a host of studies comparing the contraceptive skin patch or vaginal ring to the pill. Although perfection remains elusive and choices are equally effective, the review authors were able to pinpoint some preferences.
080124203037.jpg

“Basically, all of these methods were similar in preventing pregnancy,” said lead investigator Laureen Lopez, Ph.D., research associate at Family Health International in Research Triangle Park, N.C.

(more…)

Wyeth Announces Launch of Own Generic Version of PROTONIX

Wednesday, January 30th, 2008

Wyeth ( NYSE:WYE ) and its business partner, Nycomed, today announced the U.S. launch of Wyeth’s own generic version of PROTONIX(R) tablets, in response to the at-risk launch of generic pantoprazole tablets in the U.S. by Teva Pharmaceuticals USA, Inc. on December 21, 2007.(original article)

Stem cell therapy studies for stroke, cerebral palsy prepare for clinical trials

Wednesday, January 30th, 2008

Finding answers about optimal dosage and timing for stem cell therapy in adults with strokes and newborns with ischemic injuries is a goal of two new federally funded studies.(original article)

Schizophrenia and Healthcare: Survey Finds Treatment Barriers

Wednesday, January 30th, 2008

Mental Health America today released results of the first national online survey to examine overall healthcare in mental health settings from the perspective of both people with schizophrenia and psychiatrists.(original article)

Kidney cancer drug attacks a major type of acute myeloid leukemia

Tuesday, January 29th, 2008

A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.(original article)

Lungs’ mast cells could provide new treatment target for asthma, other respiratory disease

Tuesday, January 29th, 2008

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.(original article)

New target found for asthma

Tuesday, January 29th, 2008

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma — pointing to a potential new target for treatment against the illness.(original article)

U.S. PTO’s rejection of Gilead’s antiretroviral patents might affect applications in India

Monday, January 28th, 2008

Last week’s rejection by the U.S. Patent and Trademark Office of four patents on Gilead Sciences’ antiretroviral drug Viread might affect patent applications for the drug in India, the Times of India reports.(original article)

M. D. Anderson, AstraZeneca Form Alliance to Advance Understanding of Cancer-Related Pain

Thursday, January 24th, 2008

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.(original article)

New Method Enables Design, Production of Extremely Novel Drugs

Wednesday, January 23rd, 2008

A new chemical synthesis method based on a catalyst worth many times the price of gold and providing a far more efficient and economical method than traditional ones for designing and manufacturing extremely novel pharmaceutical compounds is described by its University at Buffalo developers in a review article in the current issue of Nature.(original article)

OTC cough medicine: Not worthwhile for children or adults?

Wednesday, January 23rd, 2008

Alert parents know that small children should not take over-the-counter cough medications.(original article)

Synthesis of natural molecule could lead to better anti-cancer drugs

Wednesday, January 23rd, 2008

In early 2007, Northwestern University chemist Karl Scheidt’s interest was piqued when marine chemist Amy Wright reported in the Journal of Natural Products that a new natural compound derived from an uncommon deep-sea sponge was extremely effective at inhibiting cancer cell growth.(original article)

Anti-Alzheimer’s Mechanism In Omega-3 Fatty Acids Found

Wednesday, January 23rd, 2008

It’s good news that we are living longer, but bad news that the longer we live, the better our odds of developing late-onset Alzheimer’s disease.

071226003611.jpg

Fish oil, and its key ingredient omega-3 fatty acids (found in fatty fish like salmon), is a deterrent against Alzheimer’s, and researchers have identified the reasons why.

Many Alzheimer’s researchers have long touted fish oil, by pill or diet, as an accessible and inexpensive “weapon” that may delay or prevent this debilitating disease. Now, UCLA scientists have confirmed that fish oil is indeed a deterrent against Alzheimer’s, and they have identified the reasons why.

(more…)

What is Asbestosis?

Wednesday, January 23rd, 2008

What is this Condition?

This lung condition is characterized by widespread filling and inflammation of the lung spaces with asbestos fibers. It can develop as long as 15 to 20 years after regular exposure to asbestos has ended. A potent cocarcinogen, asbestos aggravates the risk of lung cancer in cigarette smokers.

What causes it?

Asbestosis is caused by the inhalation of small asbestos fibers. These fibers move in the direction of airflow and penetrate the breathing passages. Sources include the mining and milling of asbestos, the construction industry (where asbestos is used in a prefabricated form), and the fireproofing and textile industries. It has also has been used in the production of paints, plastics, and automobile brake and clutch linings.

Asbestos-related diseases develop in families of workers as a result of exposure to the fibrous dust shaken off workers’ clothing at home. Asbestosis also strikes people who are exposed to fibrous dust or waste piles from nearby asbestos plants.

Inhaled fibers become encased in a brown, protein like sheath rich in iron called ferruginous bodies or asbestos bodies found in sputum and lung tissue.

What are its symptoms?

The first symptom is usually shortness of breath on exertion, typically after 10 years’ exposure. As lung damage becomes more extensive, this increases, until eventually the person is short of breath, even at rest. Advanced disease also causes a cough, chest pain, recurrent respiratory infections, and rapid breathing.

Asbestosis may cause complications, such as an enlarged heart and pulmonary hypertension. Club-shaped fingers commonly occur.

How is it Diagnosed?

The persons history reveals occupational, family, or neighborhood exposure to asbestos fibers. A physical exam reveals characteristic, dry crackles at the bases of the lungs. An arterial blood gas test reveals a decreased oxygen level and a low carbon dioxide level. Finally, a chest X-ray and pulmonary function studies help diagnose this disease.

How is it Treated?

This disease can’t be cured. The goal of treatment is to relieve respiratory symptoms and, in advanced disease, to control the complications.

Respiratory symptoms may be relieved by chest physical therapy techniques such as controlled coughing. Aerosol therapy, inhaled mucolytics, and increased fluids (at least 3 quarts [3 liters] daily) may also help relieve respiratory symptoms. Diuretics, digitalis glycoside preparations, and salt restriction may be indicated for people with cor pulmonale. Oxygen deficiency requires oxygen administration by mask or by a mechanical ventilator. Respiratory infections require prompt administration of antibiotics.

What can a person with asbestosis do?

To prevent infections, avoid crowds and persons with infections and receive influenza and pneumococcal vaccines.

To improve your breathing, undergo physical reconditioning, conserve your energy in daily activities, and use relaxation techniques.


MedsList © All rights reserved. Design by Suono. Sponsored by MS Doors. Powered by WordPress.